Natera, Inc.
NASDAQ:NTRAMedical - Diagnostics & Research
+$2.23 today
- Market cap
- $41.98B
- Beta
- 1.54
- P/E (TTM)
- -143.0
- EPS (TTM)
- -$1.60
Volume 1.96M
Average 1.41M
NTRA Net Change in Cash
Combined operating, investing, financing, and currency effects on the cash balance during the period.
Natera, Inc.NASDAQ: NTRA
Net Change in Cash · Q2 FY2026 · quarter ended Jun 2026
Net change in cash declines year over year
Q2 FY2026 net change in cash of $3.57M fell 86.4% year over year, behind the -55.0% change in trailing-twelve-month net change in cash. Sequentially, it fell 69.7% from the prior quarter. Over 3 fiscal years it compounded at -30.1% a year.
Context
- Net change in cash amounted to 5.7% of revenue in FY2025, down 12.2 pp from a year earlier.
- Net change in cash increased in 1 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth recovers from -86.4% toward the trailing-twelve-month pace of -55.0%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Net Change in Cash history
USD · from the cash flow
- Latest · FY2025
- 130.55M USD
- Year-over-year change
- -57.0%
- 4-year CAGR
- +38.2%
| Period | Period end | Net Change in Cash | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 130.55M | -57.0% |
| FY2024 | 2024-12-31 | 303.49M | +72.4% |
| FY2023 | 2023-12-31 | 176M | -53.9% |
| FY2022 | 2022-12-31 | 381.48M | +966.8% |
| FY2021 | 2021-12-31 | 35.76M | — |
Net Change in Cash vs competitors
How NTRA compares with its peers on the latest reported figures
- NTRA's LTM Jun 2026 net change in cash of $91.48M is the 2nd largest of the 8 companies compared; the peer median is $2.59M.
- Its year-over-year change of -55.0% is the 3rd highest of 7, against a peer median of -133.4%.
- Net change in cash amounts to 3.4% of revenue for NTRA, versus a peer median of 13.7%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
BLLNBillionToOne, Inc. | LTM Jun 2026 | $359.67M | — | — | 90.5% |
| LTM Jun 2026 | $91.48M | -55.0% | -30.1% | 3.4% | |
| LTM Jun 2026 | $80.04M | +605.0% | — | 14.2% | |
| LTM Mar 2026 | $43.88M | -444.5% | -61.3% | 13.7% | |
| LTM Mar 2026 | $25M | +643.5% | — | 3.0% | |
WGSGeneDx Holdings Corp. | LTM Jun 2026 | $13.8M | -176.5% | — | 3.0% |
| LTM Mar 2026 | $2.59M | -90.4% | — | 4.0% | |
| LTM Mar 2026 | $1.06M | -206.5% | -85.0% | 1850.9% | |
| Peer median (excluding NTRA) | $2.59M | -133.4% | -73.1% | 13.7% | |
Competitors are the stored peer set for NTRA. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | (471.72M) | (547.8M) | (434.8M) | (190.43M) | (208.16M) |
| Depreciation & Amortization | 11.25M | 16.7M | 24.1M | 30.97M | 43.48M |
| Deferred Income Tax | 0 | 0 | 0 | 0 | 0 |
| Stock-Based Compensation | 115.22M | 152.38M | 191.81M | 274.43M | 354.4M |
| Change in Working Capital | (45.6M) | (83.15M) | (47.95M) | 2.14M | 10.05M |
| Accounts Receivables | (43.51M) | (122.31M) | (33.9M) | (35.88M) | 20.75M |
| Inventory | (6.88M) | (8.5M) | (5.35M) | (3.99M) | (20.87M) |
| Accounts Payables | 19.22M | 5.46M | (15.46M) | 13.21M | 753K |
| Other Working Capital | (14.44M) | 42.2M | 6.76M | 28.79M | 9.41M |
| Other Non-Cash Items | 55.61M | 30.36M | 19.89M | 18.55M | 15.53M |
| Operating Cash Flow | (335.24M) | (431.5M) | (246.96M) | 135.66M | 215.3M |
| Capital Expenditures | (41.03M) | (47.7M) | (39.2M) | (66.42M) | (106.19M) |
| Acquisitions (Net) | 0 | 0 | 0 | 0 | (16.02M) |
| Purchases of Investments | (876.1M) | (86.95M) | (98.3M) | (124.68M) | 0 |
| Sales of Investments | 720.49M | 464.98M | 306M | 339.22M | 23M |
| Other Investing Activities | (8.56M) | 0 | 0 | (10.5M) | 0 |
| Investing Cash Flow | (205.19M) | 330.34M | 168.5M | 137.62M | (132.21M) |
| Debt Repayment | 0 | 30M | 0 | (82K) | 0 |
| Common Stock Issued | 576.19M | 452.64M | 254.46M | 30.29M | 47.46M |
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 0 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | 576.19M | 482.64M | 254.46M | 30.2M | 47.46M |
| Effect of Forex Changes | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | 35.76M | 381.48M | 176M | 303.49M | 130.55M |
| Free Cash Flow | (376.27M) | (479.2M) | (286.15M) | 69.24M | 109.11M |
Natera, Inc.
NASDAQ:NTRA
Intrinsic Alpha fair value
Locked
Current Price
$289.50
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.